IMMUNIZATIONS - (U) - MenACWY-CRM (MENVEO)

® or MENACTRA® as described below and in the Table below on the “Recommended Vaccination Schedule and Intervals.” For children aged 2 through 18 months with anatomic or functional asplenia (including sickle cell disease), administer a 4-dose infant series of . MENVEO ................
................